Dianthus Therapeutics | الأصول



Assets تغيير تاريخ
Adcock Ingram Holdings ZAR 8.35B 25.86M 2024-06
Alaunos Therapeutics USD 3.55M 1.13M 2024-09
Avita Medical AUD 79.71M 8.12M 2024-12
Celltrion KRW 20.31T 180.03B 2024-09
Cspc Pharmaceutical CNY 47.9B 1.61B 2024-06
Dianthus Therapeutics USD 354.25M 14.71M 2024-09
Ecofibre AUD 71.25M 1.95M 2024-06
IQVIA Holdings USD 26.9B 281M 2024-12
Kangmei Pharma CNY 14.19B 63.4M 2024-09
Knight Therapeutics CAD 962.29M 16.93M 2024-09
Laboratorios Farma EUR 857.32M 78.66M 2024-06
Malin Corporation EUR 128.4M 11.8M 2024-06
Medical Developments International AUD 59.16M 31.9M 2024-06
Moderna USD 14.14B 1.66B 2024-12
Neuren Pharmaceuticals AUD 409.71M 181.55M 2024-12
Organigram Holdings CAD 479.21M 71.35M 2024-12
Organon & Co USD 12.75B 598M 2024-09
Pharma Mar EUR 349.64M 16.52M 2024-12
Qiagen NV USD 5.69B 580.57M 2024-12
Revvity USD 12.39B 377.26M 2024-12
Sartorius EUR 9.79B 148.6M 2024-09
Sino Biopharmaceutical CNY 66.7B 3.1B 2024-06
Tectonic Therapeutic USD 168.72M 25.19M 2024-09
Tilray USD 4.19B 70.11M 2024-11
Viatris USD 41.5B 3.25B 2024-12
Xeris Pharmaceuticals USD 323.06M 1.96M 2024-12
Zz Pientze Pharmaceu 17.99B 940.45M 2024-09



Dianthus Therapeutics الأصول - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2025.